NCT00134186
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Methodist Hospital Houston, Texas, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT00291369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Centre Leon Berard Lyon, France
Active, Not Recruiting
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT04071223
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Rush MD Anderson Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
NCT03055013
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
Active, Not Recruiting
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
NCT03284385
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCSF Medical Center-Mount Zion San Francisco, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
NCT04626518
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of California at San Francisco ( Site 3008) San Francisco, California, United States
- Yale-New Haven Hospital-Yale Cancer Center ( Site 3011) New Haven, Connecticut, United States
- University of Chicago ( Site 3013) Chicago, Illinois, United States
- University of Iowa ( Site 3012) Iowa City, Iowa, United States
Active, Not Recruiting
Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
NCT04106349
- Conditions
- Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +14 more
- Locations
-
- Onze-Lieve-vrouw Ziekenhuis Aalst Aalst, Belgium
- Imeldaziekenhuis Bonheiden, Belgium
- Clinique Saint-Luc Bouge Bouge, Belgium
- AZ Sint-Jan Brugge Bruges, Belgium
Active, Not Recruiting
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
NCT04626479
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of California at San Francisco ( Site 1008) San Francisco, California, United States
- Yale-New Haven Hospital-Yale Cancer Center ( Site 1011) New Haven, Connecticut, United States
- University of Chicago ( Site 1013) Chicago, Illinois, United States
- University of Iowa ( Site 1012) Iowa City, Iowa, United States
Active, Not Recruiting
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
NCT03647878
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Landeskrankenhaus Hochsteiermark Leoben, Austria
- Kepler Universitätsklinikum GmbH Linz, Austria
- Uniklinikum Salzburg Salzburg, Austria
- Salzkammergutklinikum Vöcklabruck Vöcklabruck, Austria